最新ニュース Nomura Holdings (NYSE:NMR) 株価情報

Nomura Holdings

Nomura Holdings Inc is a financial services group in Japan and operates offices in countries and regions worldwide including Japan, the U.S., the U.K., Singapore, and the Hong Kong Special Administrative Region ("Hong Kong") through its subsidiaries. The company's clients include individuals, corporations, financial institutions, governments, and governmental agencies. The company's business consists of Wealth Management*, Investment Management, and Wholesale. The company generates the majority of its revenue from the wholesale segment. The Wholesale Division consists of two businesses, Global Markets, which is mainly engaged in the trading, sales, and structuring of financial products, and Investment Banking which is engaged in advisory, financing, and solutions businesses.

Nomura Holdings Inc ADR American Depositary Shares

Nomura Holdings Inc

Numeraire - United States Dollar

Neumora Therapeutics, Inc. - Common Stock

Neumora Therapeutics Inc

NEMAURA MEDICAL INC by Nemaura Medical, Inc.

Nemaura Medical Inc

NAMIBIA CRITICAL METALS by Namibia Critical Metals Inc.

Namibia Critical Metals Inc

Newmark Group, Inc. - Class A Common Stock

Newmark Group Inc

Numeral Ltd

NATIONAL MILK RECORDS PLC by National Milk Records Plc.

NAMURA SHIPBUILD CO ORD by Namura Shipbuilding Co. Ltd.

Namura Shipbuilding Co Ltd

It is all true.
The market is priced at ridiculous levels.
The current multiples of earnings, cash flow, assets, and dividends of the S&amp;P 500 (Ticker: SPY) imply that we live in a perfect world and perfection will continue to grow at a double-digit rate.
We do not live in a perfect world.
The bond market, usually the far brighter and less emotional market, has been showing great concern and a smudge of outright fear in recent weeks. It has reentered a downtrend even as stocks went higher.
Should we just sell and hide under a rock on top of a mountain somewhere until the headlines improve?
Probably not.
If we have learned nothing else, it is that markets can remain irrational, unrealistic, and overpriced for a very long time.
What we can do is become cautious.
Avoid companies where insiders are selling as the price declines.
Avoid stocks that are being sold by smart money investors with outstanding track records.
Flipping that over, if you are looking to put money to work, look for companies where insiders are making large open-market purchases of shares of the companies they manage.
Look for companies where investors with great track records are stepping up and establishing new company positions.
I recently sat down to review institutional buying and selling activity, and a couple of purchases caught my eye.
One such smart money buy was a biotech company.
Let me be upfront and say that I know nothing about biotechnology.
I am not a doctor, I have never played a doctor on television, and I generally avoid small-cap biotech stocks because that is where money goes to die.
There have been a handful of exceptions over the years, and they were all the result of noticing that a very smart, very successful investor had bought a lot of stock.
I noticed that Harris Kupperman of Praetorian Capital had purchased a 5.5% stake in Immune Bio (Ticker: INMB).
Kupperman, or JKuppy as he prefers to be called apparently, is not everyone&#8217;s cup of tea.
He can come across as brash, opinionated, and a tad arrogant.
He runs part of his fund in deep-value stocks and the other half in special situations.
It is almost like looking in a personality mirror.
He is also very good at what he does.
Kupperman runs his fund to do okay in what he calls standard years and to really push the edge when he feels he has uncovered opportunities in deeply undervalued markets and sectors.
It is working.
Since 2019, his fund is up a little over 700%.
Immune Bio is working on developing drugs using its core research that could help treat depression and Alzheimer&#8217;s.
Both are massive markets that could lead to substantial partnership opportunities or licensing deals for a company that progresses in developing a successful drug.
The folks at Praetorian are not the only ones excited about the stock. Raymond James analyst Gary Nachman recently wrote a favorable report with an $18 price target for shares of Immune Bio.
That is almost three times the current stock price.
The true test of another intelligence is how much they agree with me, and a closer peek into Praetorian&#8217;s portfolio at the end of the third quarter shows that he bought shares of one of my favorite Japanese firms, Nomura (Ticker: NMR).
Nomura has had one of those years that just naturally attracts my attention.
One staffer tried to manipulate the bond market, and the firm had to pay a fine and temporarily lost its status as a primary dealer.
Then, a Nomura staffer was arrested for attempting to murder an elderly client.
These are not the kind of headlines that attract enthusiastic buyers of your stock.
None of this impacts a firm of Nomura&#8217;s size, but it creates a cloud around the stock that creates buying opportunities.
The scandals have partially masked that business at Nomura is pretty good. Revenues are rising, and profits more than doubled, as the company reported its largest profits in four years.
The company is buying back stock and paying a cash dividend of 4.3%, rewarding shareholders with its excess cash.
The company is increasing its presence outside of Asia, focusing on wealthy markets like the Americas, India and the Middle East. Early results are promising, with solid gains in the number of customers for both wealth management and investment banking in these markets.
In spite of the strong results and positive outlook, the stock is trading at just 82% of tangible book value and less than ten times earnings.
These are uncertain times in financial markets.
There are as many possible outcomes as there are questions about what lies ahead in 2025.
Avoiding stocks where insiders and the smart money are selling and accumulating the ones they are buying can help us navigate turbulent waters profitably.

Opinion

INMB

C-Suite Buy of the Week: Executive Moves from Biotech to Banking

Archegos Capital Management founder Bill Hwang was sentenced on Wednesday to 18 years in prison for fraud and market manipulation tied to the fund's <a href="https://www.benzinga.com/news/24/05/38718096/bill-hwangs-trial-begins-over-archegos-fund-collapse-what-to-expect">dramatic collapse in 2021.&nbsp;</a>
The Details: Hwang was sentenced by U.S. District Judge Alvin Hellerstein in New York to slightly less time than the 21 years prosecutors had sought in the case. 
Hwang's lawyers had asked that he be given no prison time at all and Hwang asked the judge on Wednesday to impose a sentence that would allow him to continue to serve society. He also said that he felt "deep pain" about what happened at Archegos, according to a Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-11-20/archegos-founder-bill-hwang-sentenced-to-18-years-in-prison?sref=TBDibEcD">report.</a>
Read More: <a href="https://www.benzinga.com/etfs/24/11/42044642/trump-appears-frustrated-as-elon-musk-chimes-in-on-treasury-secretary-adds-more-names-to-a-list-of-potential-picks">Trump Appears &#8216;Frustrated&#8217; As Elon Musk Chimes In On Treasury Secretary, Adds More Names To Short List&nbsp;</a>
Hellerstein said Hwang's request for no jail time was "utterly ridiculous" considering the amount of money involved. 
"The amount of losses that were caused by your conduct are larger than any amount of losses I've deal with as a judge," Hellerstein said.
The judge also compared Hwang to FTX founder Sam Bankman-Fried, who received a 25-year sentence for fraud.
"What was worse? Mr. Bankman-Fried's fraud or Mr. Hwang's fraud?" Hellerstein asked.
The jury found that Hwang directed Archegos staff to relay that the firm had large positions in companies such as Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>). Archegos actually invested heavily in a small group of stocks that could be more easily manipulated. 
The collapse at Archegos contributed <a href="https://www.benzinga.com/news/22/11/29835374/troubled-lender-credit-suisse-flags-massive-loss-for-q4-as-it-speeds-up-turnaround-plans">to the demise </a>of Credit Suisse Group AG and rippled through Wall Street causing significant losses at Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), UBS Group AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBS#NYSE">UBS</a>), Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) and other banks.
Former Archegos CFO Patrick Halligan was convicted alongside Hwang earlier in 2024 and will be sentenced separately in January.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/41949068/bitcoin-could-reach-1-million-by-2037-economist-says-buy-of-a-lifetime-opportunity">Bitcoin Could Reach $1 Million By 2037, Economist Says: &#8216;Buy Of A Lifetime&#8217; Opportunity</a></li>
</ul>
Photo: Shutterstock

News

Legal

Global

General

AAPL

MSFT

Hedge Funder Linked To Credit Suisse Collapse Gets 18 Year Prison Sentence For Fraud, Market Manipulation

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Tuesday.
Shares of Emerson Electric Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) rose sharply during Monday's session after the company reported better-than-expected fourth-quarter financial results and issued FY25 adjusted EPS guidance above estimates. Also, the company announced it increased return of capital to shareholders with plans to repurchase <a href="https://www.benzinga.com/news/earnings/24/11/41748679/emerson-electric-gains-on-q4-earnings-beat-and-fy25-growth-forecast-eyes-aspentech-buyout">approximately $2B in FY25.</a>
Net sales growth of 13% year over year to $4.62 billion, beating the consensus of $4.57 billion. Underlying sales were up 4%, and underlying orders increased by 2% in the quarter. Adjusted EPS improved 15% to $1.48, beating the consensus of $1.47.
Emerson Electric shares jumped 6.6% to $117.01 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Vimeo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) shares jumped 42.7% to $6.86 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter sales guidance above estimates.</li>
<li>Gogo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGO#NASDAQ">GOGO</a>) gained 29.3% to $8.47 after the company reported better-than-expected third-quarter financial results.</li>
<li>Astera Labs Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) rose 29.1% to $90.14 after the company reported better-than-expected third-quarter EPS and sales.</li>
<li>Aris Water Solutions Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARIS#NYSE">ARIS</a>) gained 25.8% to $20.84 following strong quarterly results.</li>
<li>Palantir Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) gained 22.4% to $50.70 after the company reported better-than-expected third-quarter financial results and issued guidance above consensus estimates.</li>
<li>UFP Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFPT#NASDAQ">UFPT</a>) rose 20.7% to $335.00 after the company reported better-than-expected third-quarter financial results.</li>
<li>Lindblad Expeditions Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIND#NASDAQ">LIND</a>) gained 20.6% to $11.28 after the company reported better-than-expected third-quarter financial results.</li>
<li>DXP Enterprises Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXPE#NASDAQ">DXPE</a>) gained 18.7% to $60.45 following strong quarterly results.</li>
<li>Century Aluminum Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENX#NASDAQ">CENX</a>) gained 17.7% to $20.66 following upbeat quarterly earnings.</li>
<li>Payoneer Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYO#NASDAQ">PAYO</a>) climbed 16% to $9.88 after the company reported better-than-expected quarterly EPS and sales and raised its FY24 revenue guidance.</li>
<li>Cushman &amp; Wakefield PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWK#NYSE">CWK</a>) gained 13.2% to $14.88 after the company reported better-than-expected quarterly adjusted EPS results.</li>
<li>Ingredion Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) rose 12.6% to $150.97 following upbeat earnings.</li>
<li>Primoris Services Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRIM#NYSE">PRIM</a>) gained 10.5% to $71.11 following strong quarterly earnings.</li>
<li>Powell Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWL#NASDAQ">POWL</a>) rose 9.1% to $293.34.</li>
<li>Cummins Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) gained 8.7% to $353.91 after the company reported better-than-expected third-quarter financial results.</li>
<li>Nomura Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) rose 7.3% to $5.64 following second-quarter results.</li>
<li>Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) gained 6.8% to $149.00 after the company reported better-than-expected quarterly financial results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41744659/jim-cramer-says-he-cant-recommend-this-major-automaker-ceva-is-way-too-high">Jim Cramer Says He Can&#8217;t Recommend This Major Automaker, Ceva Is &#8216;Way Too High&#8217;</a></li>
</ul>

Intraday Update

Markets

Movers

Trading Ideas

ALAB

ARIS

CENX

DXPE

GOGO

INGR

LIND

PAYO

PLTR

POWL

PRIM

UFPT

VMEO

Emerson Electric Posts Better-Than-Expected Results, Joins Palantir Technologies, DXP Enterprises, Cummins, Apollo Global Management And Other Big Stocks Moving Higher On Tuesday

WIIM

Nomura Holdings shares are trading higher after the company reported Q2 financial results.

Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) reported quarterly earnings of $0.22 per share. This is a 175 percent increase over earnings of $0.08 per share from the same period last year. The company reported $3.25 billion in sales this quarter. This is a 23.88 percent increase over sales of $2.62 billion the same period last year.

Earnings

Nomura Holdings Q2 EPS $0.22 Up From $0.08 YoY, Sales $3.25B Up From $2.62B YoY

ALTI

CNFR

CRBG

HOOD

IBKR

NTRS

UPST

WENA

Shares of companies within the broader financial sector are trading lower amid overall market weakness as investors react to jobs data.

JP Morgan analyst Koki Sato assumes Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) from Neutral to Neutral.

Initiation

Analyst Ratings

JP Morgan Assumes Nomura Holdings to Neutral

ALLY

Bakkt Holdings, Inc. Class A Common Stock

BKKT

FFBC

FRGE

FTFT

GOCO

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HIPO

MEGL

SLQT

TCJH

TREE

Shares of companies within the broader financial sector are trading higher amid overall market strength following Fed Chair Powell's comments about the economy and future rate cuts.

These ten large-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>Starbucks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) stock escalated 24.08% after the company announced that Chipotle Mexican Grill, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) CEO and Chairman Brian Niccol was named Starbucks&#8217; new Chairman and <a href="https://www.benzinga.com//node/40338228" target="_blank" rel="noreferrer noopener">Chief Executive Officer, effective September 9</a>.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) stock jumped 23.06% following Soros Fund Management&#8217;s disclosure in its SEC Form 13F filing, revealing that the fund has&nbsp;<a href="https://www.benzinga.com//node/40403528" target="_blank" rel="noreferrer noopener">purchased 24,898 shares of Super Micro Computer</a>.</li>
<li>Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) shares increased 20.72% following price target <a href="https://www.benzinga.com//node/40400328" target="_blank" rel="noreferrer noopener">increases from the analysts</a>.</li>
<li>Sea Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SE#NYSE">SE</a>) stock upped 18.42% after the company reported second-quarter results, and several analysts raised the <a href="https://www.benzinga.com//node/40377351" target="_blank" rel="noreferrer noopener">price target on the stock</a>.</li>
<li>Carvana Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) stock rose 17.55% amid a gain in auto-related stocks following a rise in July auto sales.</li>
<li>Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) shares jumped 17.43% &nbsp;after&nbsp;Berkshire Hathaway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) <a href="https://www.benzinga.com//node/40402528" target="_blank" rel="noreferrer noopener">added a stake</a>.</li>
<li>NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) stock gained 17.19% last week. Semiconductor stocks gained amid overall market strength following softer-than-expected PPI figures that could lead to an interest rate cut.</li>
<li>Micron Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) stock gained 16.12% in the last week amid overall market strength in semiconductor stocks following softer-than-expected PPI figures, which could lead to an interest rate cut.</li>
<li>Nomura Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) stock gained 14.48% last week.</li>
<li>Coherent Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) stock upped 14.02% after the company reported better-than-expected Q4 financial results. Several analysts raised their <a href="https://www.benzinga.com/quote/COHR/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecasts</a> on the stock.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/08/40431811/rivian-chipotle-mexican-and-sirius-xm-are-among-top-10-large-cap-losers-last-week-aug-11-aug-17-ar">Rivian, Chipotle Mexican And Sirius XM Are Among Top 10 Large Cap Losers Last Week (Aug 11-Aug 17): Are The Others In Your Portfolio?</a></li>
</ul>
Image via Nvidia Blog

Large Cap

COHR

CVNA

DELL

DKNG

MRVL

NVDA

SBUX

SMCI

ULTA

NVIDIA, Starbucks And Dell Are Among Top 10 Large Cap Gainers Last Week (Aug 11-Aug 17): Are The Others In Your Portfolio?

ACRE

ARES

ATCH

COHN

FUTU

HSBC

HTGC

JFIN

Janus Henderson Group plc Ordinary Shares

KSPI

LPLA

MOGO

MORN

NCPL

NDAQ

NRDS

PRAA

RILY

SHF Holdings, Inc. - Class A Common Stock

SHFS

SNEX

SPGI

STEP

TBBK

TROW

VCTR

VOYA

Shares of companies within the broader financial sector are trading lower amid overall weakness following concerns about recently issued US economic data.

Brighthouse Financial, Inc. - Common Stock

ENVA

OSCR

PIPR

SOFI

VALU

Shares of companies within the broader financial sector are trading lower amid overall market weakness following weak US jobs data.

Nomura Holdings shares are trading higher after the company reported a year-over-year increase in Q1 financial results.

Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) reported quarterly earnings of $0.14 per share. This is a 180 percent increase over earnings of $0.05 per share from the same period last year. The company reported $2.92 billion in sales this quarter. This is a 14.67 percent increase over sales of $2.54 billion the same period last year.

Nomura Holdings Q1 EPS $0.14 Up From $0.05 YoY, Sales $2.92B Up From $2.54B YoY

Shares of F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) shares rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter financial results and raised its FY24 earnings <a href="https://www.benzinga.com/news/earnings/24/07/40023356/f5-shares-climb-on-better-than-expected-q3-results-strong-forward-guidance">guidance above estimates</a>.
F5 reported quarterly earnings of $3.36 per share, which beat the analyst consensus estimate of $2.97 per share. Quarterly sales came in at $695.495 million, which beat the analyst consensus estimate of $686.062 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
F5 shares jumped 14.3% to $202.92 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Imunon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMNN#NASDAQ">IMNN</a>) gained 104.2% to $2.41 in pre-market trading. IMUNON will report topline results from the Phase 2 OVATION 2 study with IMNN-001 In advanced ovarian cancer on July 30.</li>
<li>Jet.AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) shares climbed 48% to $0.4422 in pre-market trading.</li>
<li>Enveric Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) rose 26.3% to $0.6289 in pre-market trading after jumping around 6% on Monday.</li>
<li>Inspirato Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPO#NASDAQ">ISPO</a>) gained 22.3% to $6.41 in pre-market trading after jumping over 50% on Monday.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) shares gained 17.4% to $99.50 in pre-market trading after the company reported better-than-expected second-quarter financial results and issued its third-quarter earnings guidance above estimates.</li>
<li>Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) gained 16.1% to $22.51 in pre-market trading after jumping 47% on Monday.</li>
<li>NIP Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIPG#NASDAQ">NIPG</a>) shares gained 15.2% to $19.00 in pre-market trading. NIP Group announced the closing of its initial public offering and partial exercise of underwriters&#8217; option to purchase additional ADSs.</li>
<li>Pharming Group N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) shares gained 10.1% to $8.30 in pre-market trading. Pharming Group will report second quarter financial results on Aug. 1.</li>
<li>Nomura Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) gained 8.2% to $6.33 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>QXO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NASDAQ">QXO</a>) shares fell 79.9% to $12.00 in pre-market trading after dipping 23% on Monday.</li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) shares declined 19.5% to $28.70 in pre-market trading after the company reported worse-than-expected third-quarter earnings results and issued fourth-quarter revenue guidance below estimates.</li>
<li>Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) shares fell 14.8% to $46.82 in pre-market trading after the company reported worse-than-expected second-quarter financial results and issued weak third-quarter revenue guidance.</li>
<li>TROOPS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROO#NASDAQ">TROO</a>) shares fell 13.2% to $3.22  in pre-market trading.</li>
<li>Woodward, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) fell 10.5% to $164.01 in pre-market trading after the company reported mixed third-quarter financial results and lowered its FY24 revenue guidance below estimates.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) shares declined 9.6% to $14.85 in pre-market trading after declining 4% on Monday.</li>
<li>Celldex Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLDX#NASDAQ">CLDX</a>) shares fell 8.6% to $38.33 in pre-market trading after reporting Phase 2 results for barzolvolimab in chronic inducible urticaria.</li>
<li>Diageo plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) fell 8.5% to $120.36 in pre-market trading after the company missed annual profit expectations.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) shares dipped 7.8% to $51.50 in pre-market trading following weak quarterly sales.</li>
<li>Amkor Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) shares fell 6.2% to $35.28 in pre-market trading after the company issued roughly in-line guidance.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/40009447/roblox-morgan-stanley-and-2-other-stocks-insiders-are-selling">Roblox, Morgan Stanley And 2 Other Stocks Insiders Are Selling</a></li>
</ul>

Pre-Market Outlook

AMKR

CLDX

ENVB

FFIV

IMNN

ISPO

JTAI

LSCC

NIPG

NVAX

PHAR

RMBS

SERV

TROO

Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket

BANC

FIBK

FULT

SBCF

SMFG

TCBI

Shares of bank stocks are trading higher amid overall market strength on rate rate cut optimism. The sector may also be up following strong earnings from Bank of America and Morgan Stanley.

Shares of banks and financial services stocks are trading lower. The sector may be experiencing uncertainty ahead of Wednesday's Fed decision.

BBDO

BENF

FIHL

ITUB

Shares of stocks within the broader financial sector are trading lower following earlier economic data. Also, the sector may be moving ahead of the upcoming Fed decision.

MUFG

Shares of Japanese banks are trading lower. The Nikkei fell after Japan's Q4 GDP was revised up, showing the country averted a technical recession and raising expectations the Bank of Japan could move away from negative rates.

As of Feb. 1, 2024, three stocks in the financial sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi"> RSI is above 70</a>, according to <a href="https://pro.benzinga.com/"> Benzinga Pro</a>.
Here&rsquo;s the latest list of major overbought players in this sector.
<h3>Nomura Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nmr#NYSE">NMR</a>)</h3>
<ul>
<li>On Jan. 31, Nomura Holdings posted a decline in quarterly EPS. The company&rsquo;s stock jumped around 29% over the past month and has a <a href="https://www.benzinga.com/quote/NMR">52-week high of $5.91 </a>.</li>
<li>RSI Value: 74.49</li>
<li>NMR Price Action: Shares of Nomura gained 10.2% to close at $5.74 on Wednesday.</li>
</ul>
<h3>Citigroup Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/c#NYSE">C</a>)</h3>
<ul>
<li>On Jan. 30, Morgan Stanley analyst Betsy Graseck upgraded Citigroup from Underweight to Overweight and raised the price target from $46 to $65. The company&rsquo;s stock gained around 5% over the past five days and <a href="https://www.benzinga.com/quote/C"> has a 52-week high </a> of $57.95.</li>
<li>RSI Value: 70.64</li>
<li>C Price Action: Shares of Citigroup fell 1.6% to close at $56.17 on Wednesday.</li>
</ul>
<h3>Mastercard Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ma#NYSE">MA</a>)</h3>
<ul>
<li>On Jan. 31, Mastercard said fourth-quarter net revenues stood at $6.55 billion, up 13% Y/Y and 11% Y/Y on a neutral currency basis, beating the consensus of $6.48 billion. &ldquo;We delivered strong earnings and revenue growth for the full year 2023, driven by healthy consumer spending, cross-border volume growth of 24 percent, and the solid execution of our strategy,&rdquo; said Michael Miebach, CEO of Mastercard. &ldquo;In the fourth quarter, we signed the third U.S. regulated bank debit portfolio flip to our network within the last twelve months.&rdquo; The company&rsquo;s stock gained around 6% over the past month and has a <a href="https://www.benzinga.com/quote/MA"> 52-week high </a> of $462.00.</li>
<li>RSI Value: 78.22</li>
<li>MA Price Action: Shares of Mastercard gained 0.9% to close at $ 449.23 on Wednesday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/01/36865541/16-5m-bet-on-this-healthcare-stock-check-out-these-4-stocks-insiders-are-buying"> $16.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying </a>

Short Ideas

Top 3 Financial Stocks That May Keep You Up At Night In February

Shares of Advanced Micro Devices, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amd#NASDAQ">AMD</a>) shares declined 3.8% to $165.49 following fourth-quarter results.
AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on revenue of $6.17 billion.
AMD shares dipped 3.8% to $165.49 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Connexa Sports Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnxa#NASDAQ">CNXA</a>) shares jumped 204% to $0.6049. Connexa said it has regained compliance with Nasdaq minimum shareholder equity rule.</li>
<li>Minim, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) shares climbed 76.4% to $4.48. David E. Lazar disclosed a 51% active stake in Minim Inc.</li>
<li>Powell Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/powl#NASDAQ">POWL</a>) shares gained 49% to $121.89 after the company reported better-than-expected first-quarter financial results and raised its quarterly dividend.</li>
<li>Lytus Technologies Holdings PTV. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyt#NASDAQ">LYT</a>) climbed 46.5% to $0.1180 after falling around 7% on Tuesday.</li>
<li>Ashford Hospitality Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aht#NYSE">AHT</a>) jumped 32% to $1.77.</li>
<li>2seventy bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsvt#NASDAQ">TSVT</a>) rose 31.6% to $5.28. 2seventy Bio said it will focus exclusively on commercialization and development of Abecma and sell its R&amp;D pipeline to Regeneron. Leerink Partners analyst Daina Graybosch upgraded 2seventy bio from Market Perform to Outperform and raised the price target from $5 to $18.</li>
<li>Trinity Biotech plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trib#NASDAQ">TRIB</a>) gained 29.5% to $0.5638. Trinity Biotech announced acquisition of the CGM assets of Waveform Technologies, Inc.</li>
<li>Kuke Music Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kuke#NYSE">KUKE</a>) rose 23.7% to $1.25.</li>
<li>Vaxart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vxrt#NASDAQ">VXRT</a>) jumped 20.9% to $1.1850. B. Riley Securities analyst Mayank Mamtani upgraded Vaxart from Neutral to Buy and announced a $2 price target.</li>
<li>Envirotech Vehicles, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evtv#NASDAQ">EVTV</a>) gained 20.6% to $1.75.</li>
<li>Ensysce Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ensc#NASDAQ">ENSC</a>) gained 19.6% to $1.7232. Ensysce Biosciences reported completion of a constructive end of Phase 2 meeting with the FDA regarding its lead &#39;next generation&#39; analgesic, PF614.</li>
<li>Plug Power Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plug#NASDAQ">PLUG</a>) climbed 17.8% to $4.3950 after Roth MKM upgraded the stock from Neutral to Buy and raised its price target from $4.5 to $9.</li>
<li>DocGo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dcgo#NASDAQ">DCGO</a>) gained 15.8% to $3.9497 after the company announced a share buyback program of up to $36 million.</li>
<li>Ashland Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ash#NYSE">ASH</a>) jumped 14.5% to $92.50 after the company reported mixed first-quarter financial results and issued guidance.</li>
<li>Jin Medical International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zjyl#NASDAQ">ZJYL</a>) rose 12.5% to $236.64.</li>
<li>LendingClub Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lc#NYSE">LC</a>) gained 12.3% to $9.81 after the company reported better-than-expected quarterly financial results.</li>
<li>Nomura Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nmr#NYSE">NMR</a>) rose 12.2% to $5.84 following third-quarter results.</li>
<li>Paramount Global (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/para#NASDAQ">PARA</a>) gained 10.4% to $15.10. Byron Allen offered $14.3 billion to buy all of the outstanding shares of Paramount Global, Bloomberg reported.</li>
<li>Revelation Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/revb#NASDAQ">REVB</a>) gained 10.3% to $8.77 after dipping around 39% on Tuesday.</li>
<li>Nyxoah S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nyxh#NASDAQ">NYXH</a>) shares rose 9.1% to $8.88 after dipping 34% on Tuesday.</li>
<li>Stryker Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/syk#NYSE">SYK</a>) gained 5.8% to $335.28 after the company reported better-than-expected fourth-quarter financial results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Nuvve Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvve#NASDAQ">NVVE</a>) shares dipped 65.8% to $1.1401. Nuvve announced pricing of $9.6 million underwritten public offering of 4.8 million shares of common stock at $2.00 per share.</li>
<li>Remark Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mark#NASDAQ">MARK</a>) shares fell 36% to $0.80. Remark Holdings shares jumped 264% on Tuesday following a Tweet from the company&#39;s X account suggesting an unconfirmed deal with Microsoft..</li>
<li>New York Community Bancorp, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nycb#NYSE">NYCB</a>) fell 34.5% to $6.80 after the company reported worse-than-expected fourth-quarter financial results and reduced its quarterly dividend.</li>
<li>GRI Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gri#NASDAQ">GRI</a>) fell 28.6% to $2.05.</li>
<li>Genprex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnpx#NASDAQ">GNPX</a>) declined 28% to $0.1931. Genprex announced a 1-for-40 reverse stock split effective Feb. 2, 2024.</li>
<li>Evaxion Biotech A/S (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evax#NASDAQ">EVAX</a>) fell 24% to $4.3999.</li>
<li>TuSimple Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsp#NASDAQ">TSP</a>) declined 23.4% to $0.2220.</li>
<li>Rail Vision Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvsn#NASDAQ">RVSN</a>) fell 21.9% to $11.70.</li>
<li>American Superconductor Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amsc#NASDAQ">AMSC</a>) shares declined 18.2% to $0.20 after the company announced a proposed public offering of common stock.</li>
<li>Extreme Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/extr#NASDAQ">EXTR</a>) fell 15.8% to $14.02 after the company reported mixed second-quarter financial results and issued guidance.</li>
<li>Rockwell Automation, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rok#NYSE">ROK</a>) declined 15.3% to $260.07 following weak earnings.</li>
<li>SMX (Security Matters) Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smx#NASDAQ">SMX</a>) shares fell 14.2% to $0.4067 after jumping 47% on Tuesday.</li>
<li>Synaptogenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snpx#NASDAQ">SNPX</a>) fell 13% to $0.1864 after gaining 12% on Tuesday.</li>
<li>LSB Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lxu#NYSE">LXU</a>) fell 9.5% to $7.51. UBS analyst Joshua Spector downgraded LSB Industries from Buy to Neutral and lowered the price target from $11 to $9.</li>
<li>MarketAxess Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mktx#NASDAQ">MKTX</a>) fell 8.8% to $250.01 following weak sales.</li>
<li>Teradyne, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ter#NASDAQ">TER</a>) shares declined 8.2% to $95.99 after the company posted downbeat fourth-quarter sales and issued weak forecast for the first quarter.</li>
<li>Oblong, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oblg#NASDAQ">OBLG</a>) declined 8.1% to $0.20 trading after gaining around 24% on Tuesday.</li>
<li>Solid Biosciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sldb#NASDAQ">SLDB</a>) fell 7.5% to $7.47.</li>
<li>Alphabet Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goog#NASDAQ">GOOG</a>) (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>) shares fell 6.2% to $143.60. Alphabet posted better-than-expected earnings results for its fourth quarter on Tuesday. However, Google&rsquo;s advertising sales came in short of market estimates.</li>
<li>Heartland Financial USA, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htlf#NASDAQ">HTLF</a>) fell 5.5% to $36.54.</li>
<li>Group 1 Automotive, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gpi#NYSE">GPI</a>) fell 5.5% to $266.64 after the company reported mixed fourth-quarter financial results.</li>
<li>Novartis AG (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nvs#NYSE">NVS</a>) fell around 3% to $104.69 following weak quarterly results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/01/36867301/bitcoin-falls-below-43-000-following-adp-report-blur-manta-network-among-top-losers"> Bitcoin Falls Below $43,000 Following ADP Report; Blur, Manta Network Among Top Losers</a>

Penny Stocks

Small Cap

AMSC

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

DCGO

ENSC

EVAX

EVTV

EXTR

GNPX

GOOG

GOOGL

ALPS ETF Trusthen & Steers Global Realty Majors ETF

HTLF

KUKE

MARK

MINM

MKTX

NVVE

NYCB

NYXH

OBLG

PARA

PLUG

REVB

RVSN

SLDB

SNPX

TRIB

TSVT

VXRT

Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Comments

Nomura Holdings

ニュース

最新ニュース Nomura Holdings (NYSE:NMR) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル